DETROIT - From Ford to Walmart to Procter & Gamble, a growing number of iconic American companies are warning that President Donald Trump's tariffs on U.S. imports are raising their costs and prices. Jim Hackett, CEO of Ford, the second-largest U.S.-based automaker, said Wednesday that Trump's taxes on imported steel and aluminum are costing Ford $1 billion and threatening to ignite price increases across the auto industry. Likewise, Walmart, America's largest retailer, has told the administration that Mr. Trump's latest round of taxes -- on $200 billion of Chinese imports -- could increase prices for its shoppers. Walmart specifically mentioned items ranging from car seats, cribs and backpacks to hats, pet products and bicycles. Procter & Gamble, the consumer products giant, has warned of both potential price increases and job losses as a result of the tariffs. In the meantime, drinking Coca-Cola is costing more because of the U.S. tariffs. Macy's, too, has warned of likely … [Read more...] about Corporate America warns Trump’s tariffs mean price hikes
Cost based pricing
More US corporate giants warn tariffs will mean price hikes
Tom Krisher and Josh Boak, Ap Business Writers Updated 9:09 pm PDT, Wednesday, September 26, 2018 FILE- In this Jan. 14, 2018, file photo Ford President and CEO Jim Hackett prepares to address the media at the North American International Auto Show in Detroit. Hackett said Wednesday, Sept. 16, during a television interview that the Trump administration's tariffs on imported steel and aluminum will cost the company $1 billion. less FILE- In this Jan. 14, 2018, file photo Ford President and CEO Jim Hackett prepares to address the media at the North American International Auto Show in Detroit. Hackett said Wednesday, Sept. 16, during a ... more Photo: Carlos Osorio, AP Photo: Carlos Osorio, AP Image 1 of / 1 Caption Close Image 1 of 1 FILE- In this Jan. 14, 2018, file photo Ford President and CEO Jim Hackett prepares … [Read more...] about More US corporate giants warn tariffs will mean price hikes
CMS looks to develop consumer comparative pricing portal
Brief Dive Brief: CMS has begun searching for a company capable of building and maintaining a digital platform for comparing healthcare prices. The notice seeks information from organizations with specific experience in healthcare price comparisons and online bidding for healthcare services and interactions between consumers and providers. Depending on the responses, CMS could issue a formal request for proposals for a company to develop an online comparative pricing tool. Dive Insight: CMS has been pressing hospitals to be more transparent in their pricing of procedures and services. The agency's final rule on the Inpatient Prospective Payment System, issued earlier this month, requires hospitals to post a list of their standard charges online in a "readable machine format" and update the information at least once a year. While the transparency provision only cements what CMS already requires of hospitals, a supplementary request for information seeks input on … [Read more...] about CMS looks to develop consumer comparative pricing portal
The pros and cons of indication-specific pricing
Most products–especially commodities–are sold with a single price. You can buy an iPhone for largely the same price throughout the country. In the case of pharmaceuticals, however, there may be a case that prices should vary depending on their use. For instance, there may be a treatment which provides large benefits to patients with disease A and modest benefits to patients with disease B. A paper by Cole, Towse, Lorgelly, and Sullivan (2018) outlines three ways that drug prices could vary by indication to reflect differential value: a single drug authorised under different brand names with different prices; distinct “discounts” applied to different indications, and a single weighted average price. Types of differential pricing schemes Examples of how one could allow a drug’s price to vary by use include: Differential payment by approved indication (for example Trastuzumab for HER2+ breast cancer and gastric cancer) Differential … [Read more...] about The pros and cons of indication-specific pricing
Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric. Many details have yet to be announced. But experts who pay close attention to federal drug policy and Medicare rules say the administration is preparing to incrementally roll out a multipronged plan that tasks the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration with promoting competition, attacking the complicated drug rebate system and introducing tactics to lower what the government pays for drugs. Mark McClellan, director of the Duke-Margolis Center for Health Policy in Durham, N.C., and a former CMS administrator, said that although none of the initial steps has “fundamentally transformed drug prices,” there is “a lot going on inside the administration.” Two HHS officials who are rolling out the plan, Dan Best and John O’Brien, described their … [Read more...] about Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points